mechanism of glp 1 agonist Mechanisms by which GLP-1 agonists may exert beneficial effects on the What is GLP-1 and Its

bariatric procedure volumes declined 11.4% in 2025 reversing a two-decade growth trend as semaglutide and tirzepatide provide comparable weight loss outcomes for class I and class II obesity without surgical risk, recovery time, or nutritional deficiency complications

These findings align with emerging research on GLP-1RAs as novel pharmacotherapies for AUD, a condition with limited effective treatments [33]

is the Principal Investigator of the ARISTOTELES project (Applying ARtificial Intelligence to define clinical trajectorieS for personalized predicTiOn and early deTEction of comorbidity and muLti-morbidity pattErnS) that received funding from the European Union within the Horizon 2020 research and innovation programme (grant no

In SURMOUNT-1 with non-diabetic participants, the 15mg dose produced that 20.9% figure mentioned above

A large new study suggests that GLP-1 receptor agonists may offer more protection against dementia in patients with type 2 diabetes mellitus than metformin, the long-established first-line treatment

Clinical trials of GLP-1 patches have consistently shown lower and more variable absorption compared to subcutaneous injections, meaning patients experience less predictable appetite suppression and metabolic effects